CompletedNot Applicable

Study of Blood Samples in Patients With Breast Cancer

FranceStarted 2007-11-28

Plain-language summary

RATIONALE: Studying the genes expressed in samples of blood from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to chemotherapy. PURPOSE: This clinical trial is studying blood samples in patients with breast cancer.

Who can participate

Age range18 Years – 120 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Histologically confirmed breast carcinoma * Received first-line chemotherapy (in neoadjuvant or metastatic setting) comprising anthracyclines and/or taxanes, including for a second primary cancer * Patient agrees to conservative surgery * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Menopausal status not specified * No contraindication for chemotherapy comprising anthracyclines and/or taxanes PRIOR CONCURRENT THERAPY: * See Disease Characteristics * No prior adjuvant therapy

What they're measuring

Histologic complete response (Chevallier and Sataloff) or tumor response (RECIST)

Trial details

NCT IDNCT00959556

SponsorCentre Oscar Lambret

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-01-06

View on ClinicalTrials.gov More Breast Cancer trials